Advances in neuromodulation for obsessive compulsive disorder

Author(s):
Dr Shyam Sundar Arumugham, Dr Himanshu Tyagi

Duration:
75 minutes

Credits:
1.25

Published:
June 2024

Type:
Congress webinar 2024

2024smallCongresslogo.png
Overview

Neuromodulation approaches for Obsessive Compulsive Disorder (OCD) are gaining wider acceptance in clinical practice and enhancing our understanding of OCD's neuroscience. All of the three main neuromodulation methods i.e. Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), and Deep Brain Stimulation (DBS) have proven to be effective in reducing the burden of OCD symptoms in patients who require treatment beyond the first line approaches. As we are moving towards organisational rollouts of such services, it is important that clinicians are able to understand the latest research findings, comprehend rapid developments in technology, appraise complex regulatory frameworks governing their use, and be aware of the clinical and ethical protocols in this field. In this symposium we are putting together three definitive talks on each of the three neuromodulatory approaches in OCD with relevant speakers.

Talk 1: Deep Brain Stimulation in OCD: Is there an optimal target?

Talk 2: Transcranial Magnetic Stimulation in OCD: Is there a role in treatment refractory patients?

Talk 3: Transcranial Direct Current Stimulation in OCD: What does the cognitive data suggest?

Objectives
  • Understanding the rationale and theory behind using neuromodulation for OCD treatment.
  • Learn the basics of three main neuromodulatory approaches i.e. Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), and Deep Brain Stimulation (DBS).
  • Understanding the latest technological advances in this field including differing evidence for various TMS coils and protocols in OCD, emergence of an optimal brain target in DBS for OCD, bi-directional reactive electrodes, differences between transcranial direct (tDCS) and alternate current stimulation (tACS).
  • Understanding the latest research findings in TMS, tDCS, DBS for OCD including data on their clinical safety, cognitive effects, long term follow-ups.
  • Getting an overview of regulatory, ethical and organisational considerations necessary for pursuing these approaches as a clinician.
Speakers

Chair: Dr Himanshu Tyagi, UCL Queen Square Institute of Neurology, London

Dr Shyam Sundar Arumugham, Additional Professor of Psychiatry, NIMHANS, Bengaluru

Dr Himanshu Tyagi, UCL Queen Square Institute of Neurology, London

Dr David Christmas, Consultant Psychiatrist at the Advanced interventions Service

 

 

Log in to see options tailored to you